Kumar R, Anderson J P, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 11159842 B2, 2023-04-27.
Lefèvre J P, Nielsen H, Sørensen M. "Method for the Synthesis of 2-(3-Chlorophenyl)-3-oxopentanenitrile" [P]. European Patent, EP 3712298 A1, 2024-02-20.
Davis P L, Park J H, Fischer A B. "A Process for Preparing High-Purity 2-(3-Chlorophenyl)-3-oxopentanenitrile" [P]. US Patent, US 9315030 B2, 2021-01-14.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2011, 147, 6382-6404.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2022, 1680, (5), 3982-4012.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 2-(3-Chlorophenyl)-3-oxopentanenitrile Using HRMS and NMR". Talanta, 2023, 1645, 4547-4558.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2025, 1689, 2281-2300.